| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |